Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

SVA

Sinovac Biotech (SVA)

Sinovac Biotech Ltd
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:SVA
일자시간출처헤드라인심볼기업
2024/04/3006:53Business WireSINOVAC Reports Unaudited Second Half of 2023 Financial Results and Files 2023 Annual Report on Form 20-FNASDAQ:SVASinovac Biotech Ltd
2024/02/2120:09Edgar (US Regulatory)Form 8-A12B/A - Registration of securities [Section 12(b)]: [Amend]NASDAQ:SVASinovac Biotech Ltd
2024/02/2120:02Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:SVASinovac Biotech Ltd
2024/02/2116:56Business WireSinovac Amends Shareholder Rights PlanNASDAQ:SVASinovac Biotech Ltd
2024/02/0301:19Edgar (US Regulatory)Form SC TO-T/A - Tender offer statement by Third Party: [Amend]NASDAQ:SVASinovac Biotech Ltd
2024/01/1920:58Business Wireシノバック取締役会、一方的な部分公開買い付けを全会一致で退けるNASDAQ:SVASinovac Biotech Ltd
2024/01/1904:54Business WireSinovac董事會一致反對Alternative Liquidity主動提出的部分公開收購方案NASDAQ:SVASinovac Biotech Ltd
2024/01/1904:47Business WireLe conseil d'administration de Sinovac rejette à l'unanimité une offre partielle non sollicitéeNASDAQ:SVASinovac Biotech Ltd
2024/01/1903:33Business WireDas Board of Directors von Sinovac lehnt einstimmig ein unaufgefordert abgegebenes Teilkaufangebot abNASDAQ:SVASinovac Biotech Ltd
2024/01/1821:13Edgar (US Regulatory)Form SC 14D9 - Solicitation, recommendation statementsNASDAQ:SVASinovac Biotech Ltd
2024/01/1821:00Business WireSinovac Board of Directors Unanimously Rejects an Unsolicited Partial Tender OfferNASDAQ:SVASinovac Biotech Ltd
2024/01/0906:46Edgar (US Regulatory)Form SC TO-T - Tender offer statement by Third PartyNASDAQ:SVASinovac Biotech Ltd
2023/12/0420:01Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:SVASinovac Biotech Ltd
2023/10/0322:39Edgar (US Regulatory)Form SC TO-T/A - Tender offer statement by Third Party: [Amend]NASDAQ:SVASinovac Biotech Ltd
2023/09/1521:59Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:SVASinovac Biotech Ltd
2023/09/1219:10Business Wireシノバック、新型コロナウイルスに対するSA55抗体注射剤の臨床試験について進展を報告NASDAQ:SVASinovac Biotech Ltd
2023/09/1123:36Business WireSINOVAC rend compte des progrès réalisés dans le cadre de son essai clinique concernant l’injection anti-COVID-19 à base d’anticorps SA55NASDAQ:SVASinovac Biotech Ltd
2023/09/1123:36Business WireSINOVAC informiert über die Fortschritte bei der klinischen Studie für den Anti-COVID-19-Antikörper SA55 InjectionNASDAQ:SVASinovac Biotech Ltd
2023/09/1119:16Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:SVASinovac Biotech Ltd
2023/09/1118:55Business WireSINOVAC Reports on the Clinical Trial Progress of its Anti-COVID-19 Antibody SA55 InjectionNASDAQ:SVASinovac Biotech Ltd
2023/09/0620:35Business Wireシノバック取締役会、同意なき株式の部分公開買付を全会一致で拒否NASDAQ:SVASinovac Biotech Ltd
2023/09/0601:16Business WireSinovac-Vorstand lehnt ein unangefordertes Teilübernahmeangebot einstimmig abNASDAQ:SVASinovac Biotech Ltd
2023/09/0600:36Business WireLe conseil d’administration de Sinovac rejette à l’unanimité une offre publique d’achat partielle non sollicitéeNASDAQ:SVASinovac Biotech Ltd
2023/09/0520:04Edgar (US Regulatory)Form SC 14D9 - Solicitation, recommendation statementsNASDAQ:SVASinovac Biotech Ltd
2023/09/0517:12Business WireSinovac Board of Directors Unanimously Rejects an Unsolicited Partial Tender OfferNASDAQ:SVASinovac Biotech Ltd
2023/08/3002:08Business Wireシノバック、部分的な株式公開買付を一方的に受けたことを確認NASDAQ:SVASinovac Biotech Ltd
2023/08/2922:04Business WireSinovac bestätigt den Erhalt eines unangeforderten TeilübernahmeangebotsNASDAQ:SVASinovac Biotech Ltd
2023/08/2919:05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:SVASinovac Biotech Ltd
2023/08/2919:05Business WireSinovac confirme la réception d'une offre publique d’achat partielle non sollicitéeNASDAQ:SVASinovac Biotech Ltd
2023/08/2916:07Business WireSinovac Confirms Receipt of an Unsolicited Partial Tender OfferNASDAQ:SVASinovac Biotech Ltd
 검색 관련기사 보기:NASDAQ:SVA